OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 10:14 (608 d 12:35 ago) – Posting: # 20101
Views: 3,516

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

 Admin contact
21,210 posts in 4,426 threads, 1,481 registered users;
online 14 (0 registered, 14 guests [including 9 identified bots]).
Forum time: Wednesday 22:49 UTC (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz